Literature DB >> 11851365

Kinetic model of BiP- and PDI-mediated protein folding and assembly.

Ramon Gonz lez1, Barbara A Andrews, Juan A Asenjo.   

Abstract

A mechanism for heavy chain binding protein (BiP)- and protein disulfide isomerase (PDI)- mediated protein folding and assembly has been proposed. It considers BiP chaperoning action and PDI catalytic activity. A kinetic model has been developed based on the proposed mechanism. The model was used for quantifying the influence of polypeptide concentration and ratio, and the effect of BiP and PDI concentration on the kinetics of folding and assembly. An optimum value for polypeptide concentration that minimizes assembly times was found, and different kinetic behaviors were identified for polypeptide concentrations higher or lower than the optimum. Pulse-chase experiments and the dependence of assembly time on unassembled polypeptides ratio predicted by the model are similar to those found during in vitro and in vivo folding and assembly of antibodies and human chorionic gonadotropin (hCG), as well as bovine pancreatic trypsin inhibitor (BPTI) folding. The model also explains the increase in folding and assembly rates during overexpression of BiP and PDI. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11851365     DOI: 10.1006/jtbi.2001.2478

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  9 in total

1.  Modulation of conotoxin structure and function is achieved through a multienzyme complex in the venom glands of cone snails.

Authors:  Helena Safavi-Hemami; Dhana G Gorasia; Andrew M Steiner; Nicholas A Williamson; John A Karas; Joanna Gajewiak; Baldomero M Olivera; Grzegorz Bulaj; Anthony W Purcell
Journal:  J Biol Chem       Date:  2012-08-13       Impact factor: 5.157

2.  IgG Aggregation Mechanism for CHO Cell Lines Expressing Excess Heavy Chains.

Authors:  Steven C L Ho; Tianhua Wang; Zhiwei Song; Yuansheng Yang
Journal:  Mol Biotechnol       Date:  2015-07       Impact factor: 2.695

3.  Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.

Authors:  Jake Chng; Tianhua Wang; Rui Nian; Ally Lau; Kong Meng Hoi; Steven C L Ho; Peter Gagnon; Xuezhi Bi; Yuansheng Yang
Journal:  MAbs       Date:  2015       Impact factor: 5.857

4.  Oxytocin modulates markers of the unfolded protein response in Caco2BB gut cells.

Authors:  Benjamin Y Klein; Hadassah Tamir; David L Hirschberg; Sara B Glickstein; Robert J Ludwig; Martha G Welch
Journal:  Cell Stress Chaperones       Date:  2013-11-06       Impact factor: 3.667

5.  Efficient Production of a Bioactive Bevacizumab Monoclonal Antibody Using the 2A Self-cleavage Peptide in Transgenic Rice Callus.

Authors:  Lei Chen; Xiaoyu Yang; Da Luo; Weichang Yu
Journal:  Front Plant Sci       Date:  2016-08-09       Impact factor: 5.753

6.  Alternative-splicing-based bicistronic vectors for ratio-controlled protein expression and application to recombinant antibody production.

Authors:  Stéphanie Fallot; Raouia Ben Naya; Corinne Hieblot; Philippe Mondon; Eric Lacazette; Khalil Bouayadi; Abdelhakim Kharrat; Christian Touriol; Hervé Prats
Journal:  Nucleic Acids Res       Date:  2009-09-03       Impact factor: 16.971

7.  Comparison of internal ribosome entry site (IRES) and Furin-2A (F2A) for monoclonal antibody expression level and quality in CHO cells.

Authors:  Steven C L Ho; Muriel Bardor; Bin Li; Jia Juan Lee; Zhiwei Song; Yen Wah Tong; Lin-Tang Goh; Yuansheng Yang
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

8.  Using molecular markers to characterize productivity in Chinese hamster ovary cell lines.

Authors:  Raihana Z Edros; Susan McDonnell; Mohamed Al-Rubeai
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

9.  An internal ribosome entry site (IRES) mutant library for tuning expression level of multiple genes in mammalian cells.

Authors:  Esther Y C Koh; Steven C L Ho; Zhiwei Song; Xuezhi Bi; Muriel Bardor; Yuansheng Yang
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.